Abstract
The aim of this study was to produce human parainfluenza virus type 4 (HPIV4) nucleocapsid (N) protein in yeast Saccharomyces cerevisiae expression system, to explore its structural and antigenic properties and to evaluate its applicability in serology. The use of an optimized gene encoding HPIV4 N protein amino acid (aa) sequence GenBank AGU90031.1 allowed high yield of recombinant N protein forming nucleocapsid-like particles (NLPs) in yeast. A substitution L332D disrupted self-assembly of NLPs, confirming the role of this position in the N proteins of Paramyxovirinae. Three monoclonal antibodies (MAbs) were generated against the NLP-forming HPIV4 N protein. They recognised HPIV4-infected cells, demonstrating the antigenic similarity between the recombinant and virus-derived N proteins. HPIV4 N protein was used as a coating antigen in an indirect IgG ELISA with serum specimens of 154 patients with respiratory tract infection. The same serum specimens were tested with previously generated N protein of a closely related HPIV2, another representative of genus Rubulavirus. Competitive ELISA was developed using related yeast-produced viral antigens to deplete the cross-reactive serum antibodies. In the ELISA either without or with competition using heterologous HPIV (2 or 4) N or mumps virus N proteins, the seroprevalence of HPIV4 N-specific IgG was, respectively, 46.8, 39.6 and 40.3% and the seroprevalence of HPIV2 N-specific IgG—47.4, 39.0 and 37.7%. In conclusion, yeast-produced HPIV4 N protein shares structural and antigenic properties of the native virus nucleocapsids. Yeast-produced HPIV4 and HPIV2 NLPs are prospective tools in serology.
This is a preview of subscription content, access via your institution.






References
Alayyoubi M, Leser GP, Kors CA, Lamb RA (2015) Structure of the paramyxovirus parainfluenza virus 5 nucleoprotein–RNA complex. Proc Natl Acad Sci 112:E1792–E1799. doi:10.1073/pnas.1503941112
Billaud G, Morfin F, Vabret A, Boucher A, Gillet Y, Crassard N, Galambrun C, Ferraris O, Legrand L, Aymard M, Lina B, Freymuth F, Thouvenot D (2005) Human parainfluenza virus type 4 infections: a report of 20 cases from 1998 to 2002. J Clin Virol 34:48–51. doi:10.1016/j.jcv.2005.02.001
Bulavaitė A, Lasickienė R, Vaitiekaitė A, Sasnauskas K, Žvirblienė A (2016) Synthesis of human parainfluenza virus 2 nucleocapsid protein in yeast as nucleocapsid-like particles and investigation of its antigenic structure. Appl Microbiol Biotechnol 100:4523–4534. doi:10.1007/s00253-016-7330-1
Canchola JG, Chanock RM, Jeffries BC, Christmas EE, Kim HW, Vargosko AJ, Parrott RH (1965) Recovery and identification of human myxoviruses. Bacteriol Rev 29:496–503
Cleveland SB, Davies J, McClure MA (2011) A bioinformatics approach to the structure, function, and evolution of the nucleoprotein of the order Mononegavirales. PLoS One 6:e19275. doi:10.1371/journal.pone.0019275
Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, Duks A, Griskevicius A, Johansen K, Bartha K, Kriz B, Mitis G, Mossong J, Nardone A, O’Flanagan D, DE Ory F, Pistol A, Theeten H, Prosenc K, Slacikova M, Pebody R (2013) Seroepidemiology of mumps in Europe (1996–2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect 141:651–666. doi:10.1017/S0950268812001136
Fathima S, Simmonds K, Invik J, Scott AN, Drews S (2016) Use of laboratory and administrative data to understand the potential impact of human parainfluenza virus 4 on cases of bronchiolitis, croup, and pneumonia in Alberta, Canada. BMC Infect Dis 16:402. doi:10.1186/s12879-016-1748-z
Fegan DF (2000) DNA-based molecular diagnostic techniques. Research needs for standardization and validation of the detection of aquatic animal pathogens and diseases. FAO Fish Tech Pap 395:30–37
Fry AM, Curns AT, Harbour K, Hutwagner L, Holman RC, Anderson LJ (2006) Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis 43:1016–1022. doi:10.1086/507638
Gardner SD (1969) The isolation of parainfluenza 4 subtypes A and B in England and serological studies of their prevalence. J Hyg (Lond) 67:545–550. doi:10.1017/S002217240004198X
Henrickson KJ (2003) Parainfluenza viruses. Clin Microbiol Rev 16:242–264. doi:10.1128/CMR.16.2.242
Julkunen I (1984) Serological diagnosis of parainfluenza virus infections by enzyme immunoassay with special emphasis on purity of viral antigens. J Med Virol 14:177–187
Juozapaitis M, Slibinskas R, Staniulis J, Sakaguchi T, Sasnauskas K (2005) Generation of Sendai virus nucleocapsid-like particles in yeast. Virus Res 108:221–224. doi:10.1016/j.virusres.2004.08.003
Juozapaitis M, Coiras M, Staniulis J, Sasnauskas K (2006) Synthesis of the human respiratory syncytial virus nucleoprotein in yeast Saccharomyces cerevisiae. Biologija 3:79–82
Juozapaitis M, Serva A, Kucinskaite I, Zvirbliene A, Slibinskas R, Staniulis J, Sasnauskas K, Shiell BJ, Bowden TR, Michalski WP (2007a) Generation of menangle virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae. J Biotechnol 130:441–447. doi:10.1016/j.jbiotec.2007.05.013
Juozapaitis M, Serva A, Zvirbliene A, Slibinskas R, Staniulis J, Sasnauskas K, Shiell BJ, Wang L-F, Michalski WP (2007b) Generation of henipavirus nucleocapsid proteins in yeast Saccharomyces cerevisiae. Virus Res 124:95–102. doi:10.1016/j.virusres.2006.10.008
Juozapaitis M, Zvirbliene A, Kucinskaite I, Sezaite I, Slibinskas R, Coiras M, de Ory MF, López-Huertas MR, Pérez-Breña P, Staniulis J, Narkeviciute I, Sasnauskas K (2008) Synthesis of recombinant human parainfluenza virus 1 and 3 nucleocapsid proteins in yeast Saccharomyces cerevisiae. Virus Res 133:178–186. doi:10.1016/j.virusres.2007.12.016
Kantola K, Hedman L, Arthur J, Alibeto A, Delwart E, Jartti T, Ruuskanen O, Hedman K, Söderlund-Venermo M (2011) Seroepidemiology of human bocaviruses 1-4. J Infect Dis 204:1403–1412. doi:10.1093/infdis/jir525
Kean JM, Rao S, Wang M, Garcea RL (2009) Seroepidemiology of human polyomaviruses. PLoS Pathog 5:e1000363. doi:10.1371/journal.ppat.1000363
Komada H, Tsurudome M, Bando H, Nishio M, Yamada A, Hishiyama M, Ito Y (1989a) Virus-specific polypeptides of human parainfluenza virus type 4 and their synthesis in infected cells. Virology 171:254–259
Komada H, Tsurudome M, Ueda M, Nishio M, Bando H, Ito Y (1989b) Isolation and characterization of monoclonal antibodies to human parainfluenza virus type 4 and their use in revealing antigenic relation between subtypes 4A and 4B. Virology 171:28–37
Kramer SM, Jewell NP, Cremer NE (1983) Discriminant analysis of data in enzyme immunoassay. J Immunol Methods 60:243–255
Kucinskaite-Kodze I, Pleckaityte M, Bremer CM, Seiz PL, Zilnyte M, Bulavaite A, Mickiene G, Zvirblis G, Sasnauskas K, Glebe D, Zvirbliene A (2016) New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen. Virus Res. doi:10.1016/j.virusres.2015.10.024
Kuypers J, Wright N, Ferrenberg J, Huang M-L, Cent A, Corey L, Morrow R (2006) Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol 44:2382–2388. doi:10.1128/JCM.00216-06
Lau SKP, To WK, Tse PWT, Chan AKH, Woo PCY, Tsoi HW, Leung AFY, Li KSM, Chan PKS, Lim WWL, Yung RWH, Chan KH, Yuen KY (2005) Human parainfluenza virus 4 outbreak and the role of diagnostic tests. J Clin Microbiol 43:4515–4521. doi:10.1128/JCM.43.9.4515
Lau SKP, Li KSM, Chau KY, So LY, Lee RA, Lau YL, Chan KH, Lim WWL, Woo PCY, Yuen KY (2009) Clinical and molecular epidemiology of human parainfluenza virus 4 infections in Hong Kong: subtype 4B as common as subtype 4A. J Clin Microbiol 47:1549–1552. doi:10.1128/JCM.00047-09
Liu W-K, Liu Q, Chen D-H, Liang H-X, Chen X-K, Huang W-B, Qin S, Yang Z-F, Zhou R (2013) Epidemiology and clinical presentation of the four human parainfluenza virus types. BMC Infect Dis 13:28. doi:10.1186/1471-2334-13-28
Parrott RH, Vargosko AJ, Kim HW, Bell JA, Chanock RM, Kim HW (1962) Acute respiratory diseases of viral etiology. III. Parainfluenza. Myxoviruses. Am J Public Health Nations Health 52:907–917
Petraityte R, Tamosiunas PL, Juozapaitis M, Zvirbliene A, Sasnauskas K, Shiell B, Russell G, Bingham J, Michalski WP (2009) Generation of Tioman virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae. Virus Res 145:92–96. doi:10.1016/j.virusres.2009.06.013
Petraitytė-Burneikienė R, Nalivaiko K, Lasickienė R, Firantienė R, Ėmužytė R, Sasnauskas K, Žvirblienė A (2011) Generation of recombinant metapneumovirus nucleocapsid protein as nucleocapsid-like particles and development of virus-specific monoclonal antibodies. Virus Res 161:131–139. doi:10.1016/j.virusres.2011.07.009
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera - a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. doi:10.1002/jcc.20084
Pieper U, Webb BM, Barkan DT, Schneidman-Duhovny D, Schlessinger A, Braberg H, Yang Z, Meng EC, Pettersen EF, Huang CC, Datta RS, Sampathkumar P, Madhusudhan MS, Sjolander K, Ferrin TE, Burley SK, Sali A (2011) ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res 39:D465–D474. doi:10.1093/nar/gkq1091
Rogier E, Wiegand R, Moss D, Priest J, Angov E, Dutta S, Journel I, Jean SE, Mace K, Chang M, Lemoine JF, Udhayakumar V, Barnwell JW (2015) Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission. Malar J 14:436. doi:10.1186/s12936-015-0955-1
Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Samuel D, Sasnauskas K, Jin L, Beard S, Zvirbliene A, Gedvilaite A, Cohen B (2002) High level expression of recombinant mumps nucleoprotein in Saccharomyces cerevisiae and its evaluation in mumps IgM serology. J Med Virol 66:123–130. doi:10.1002/jmv.2120
Samuel D, Sasnauskas K, Jin L, Gedvilaite A, Slibinskas R, Beard S, Zvirbliene A, Oliveira SA, Staniulis J, Cohen B, Brown D (2003) Development of a measles specific IgM ELISA for use with serum and oral fluid samples using recombinant measles nucleoprotein produced in Saccharomyces cerevisiae. J Clin Virol 28:121–129
Sasnauskas K, Buzaite O, Vogel F, Jandrig B, Razanskas R, Staniulis J, Scherneck S, Krüger DH, Ulrich R (1999) Yeast cells allow high-level expression and formation of polyomavirus-like particles. Biol Chem 380:381–386. doi:10.1515/BC.1999.050
Slibinskas R, Samuel D, Gedvilaite A, Staniulis J, Sasnauskas K (2004) Synthesis of the measles virus nucleoprotein in yeast Pichia pastoris and Saccharomyces cerevisiae. J Biotechnol 107:115–124. doi:10.1016/j.jbiotec.2003.10.018
Tamošiūnas PL, Petraitytė-Burneikienė R, Bulavaitė A, Marcinkevičiūtė K, Simutis K, Lasickienė R, Firantienė R, Ėmužytė R, Žvirblienė A, Sasnauskas K (2016) Yeast-generated virus-like particles as antigens for detection of human bocavirus 1–4 specific antibodies in human serum. Appl Microbiol Biotechnol 100(11):4935–4946. doi:10.1007/s00253-016-7336-8
Tsurudome M, Nishio M, Komada H, Bando H, Ito Y (1989) Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies. Virology 171:38–48
Tyrrell D, Bynoe M (1969) Studies on parainfluenza type 2 and 4 viruses obtained from patients with common colds. Br Med J 1(5642):471–474
Vuorinen T, Meurman O (1989) Enzyme immunoassays for detection of IgG and IgM antibodies to parainfluenza types 1, 2 and 3. J Virol Methods 23:63–70
Yano T, Fukuta M, Maeda C, Akachi S, Matsuno Y (2014) Epidemiological investigation and seroprevalence of human parainfluenza virus in Mie prefecture in Japan during 2009–2013. Jpn J Infect Dis 67(6):506–508
Yea C, Cheung R, Collins C, Adachi D, Nishikawa J, Tellier R (2009) The complete sequence of a human parainfluenzavirus 4 genome. Viruses 1:26–41. doi:10.3390/v1010026
Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32–35
Zvirbliene A, Kucinskaite I, Sezaite I, Samuel D, Sasnauskas K (2007) Mapping of B cell epitopes in measles virus nucleocapsid protein. Arch Virol 152:25–39. doi:10.1007/s00705-006-0837-5
Zvirbliene A, Pleckaityte M, Lasickiene R, Kucinskaite-Kodze I, Zvirblis G (2010) Production and characterization of monoclonal antibodies against vaginolysin: mapping of a region critical for its cytolytic activity. Toxicon 56:19–28. doi:10.1016/j.toxicon.2010.03.007
Acknowledgements
We thank Dr. Regina Ėmužytė and Dr. Regina Firantienė, who provided clinical data and patient serum specimens collected at the Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University (Lithuania).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The current study did not receive any specific grant from a funding agency in the public, commercial or not for-profit sectors.
Conflict of interest
The authors declare that they have no conflict of interest.
Animal welfare
All applicable institutional, national and international guidelines for the care and use of animals were followed. The mice were used under the licence No. LT 59-902, permission No. 184 for breeding of experimental mice and permission No. 209 for generation of polyclonal and monoclonal antibodies.
Human participants
Collection of patients’ clinical data and serum specimens was performed with informed consent following applicable ethical guidelines and was approved by the Lithuanian Bioethics Committee (No. 53, 2008-09-03).
Electronic supplementary material
ESM 1
(PDF 493 kb)
Rights and permissions
About this article
Cite this article
Bulavaitė, A., Lasickienė, R., Tamošiūnas, P.L. et al. Synthesis of human parainfluenza virus 4 nucleocapsid-like particles in yeast and their use for detection of virus-specific antibodies in human serum. Appl Microbiol Biotechnol 101, 2991–3004 (2017). https://doi.org/10.1007/s00253-017-8104-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-017-8104-0